Skip to main content

Table 5 Progression free survival and overall survival in advanced gastric cancer patients receiving first-line chemotherapy (multivariate analysis)

From: Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer

Factors Progression free survival
  Hazard ratio (95% CI) P-value
ECOG PS (≥ 2) 1.37 (1.02-1.84) 0.035
CRP (>1) 1.64 (1.28-2.09) 0.001
Bone metastasis 1.74 (1.14-2.65) 0.009
  Overall survival
  Hazard ratio (95% CI) P-value
ECOG PS (≥ 2) 1.33 (1.01-1.76) 0.037
GPS (1) 1.75 (1.37-2.26) 0.001
GPS (2) 1.79 (1.29-2.47) 0.001
Bone metastasis 1.61 (1.08-2.39) 0.017
  1. ECOG PS: Eastern Cooperative Oncology Group, performance status, CRP: C-reactive protein